当前位置:首页 - 行情中心 - 亚虹医药-U(688176) - 财务分析 - 现金流量表

亚虹医药-U

(688176)

  

流通市值:42.44亿  总市值:55.63亿
流通股本:4.36亿   总股本:5.71亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金207,293,835.96128,973,600.8258,244,929.61179,631,810.46
  收到的税费返还617,294.54616,911.43272,138.13514,567.76
  收到其他与经营活动有关的现金8,445,392.146,415,390.022,544,090.0915,752,671.77
  经营活动现金流入小计216,356,522.64136,005,902.2761,061,157.83195,899,049.99
  购买商品、接受劳务支付的现金50,033,446.0723,442,234.188,694,712.7238,918,334.38
  支付给职工以及为职工支付的现金176,250,462.21131,646,596.1970,804,398.47246,563,869.89
  支付的各项税费18,592,474.5113,285,852.656,963,347.714,260,964.52
  支付其他与经营活动有关的现金273,279,040.97161,902,397.6584,955,856.55321,106,733.37
  经营活动现金流出小计518,155,423.76330,277,080.67171,418,315.44620,849,902.16
  经营活动产生的现金流量净额-301,798,901.12-194,271,178.4-110,357,157.61-424,950,852.17
二、投资活动产生的现金流量:
  收回投资收到的现金4,556,531,835.723,331,862,525.651,532,923,130.972,395,193,359.83
  处置固定资产、无形资产和其他长期资产收回的现金净额19,144.052,044.25-69,100
  收到的其他与投资活动有关的现金1,868,9841,868,9841,868,984-
  投资活动现金流入小计4,558,419,963.773,333,733,553.91,534,792,114.972,395,262,459.83
  购建固定资产、无形资产和其他长期资产支付的现金12,766,519.159,661,336.13228,607.385,788,437.4
  投资支付的现金4,605,947,111.113,363,947,111.111,215,000,0001,590,351,305.56
  支付其他与投资活动有关的现金---1,868,802
  投资活动现金流出小计4,618,713,630.263,373,608,447.241,215,228,607.381,598,008,544.96
  投资活动产生的现金流量净额-60,293,666.49-39,874,893.34319,563,507.59797,253,914.87
三、筹资活动产生的现金流量:
  吸收投资收到的现金8,073,379.49101,191.37--
  取得借款收到的现金231,285,966.9167,546,052.3577,290,00066,200,000
  筹资活动现金流入小计239,359,346.39167,647,243.7277,290,00066,200,000
  偿还债务支付的现金36,500,00036,500,00036,500,00073,400,000
  分配股利、利润或偿付利息支付的现金7,075,691.921,312,782.07425,498.682,491,031.08
  支付其他与筹资活动有关的现金14,694,877.898,888,680.544,646,986.5567,319,840.51
  筹资活动现金流出小计58,270,569.8146,701,462.6141,572,485.23143,210,871.59
  筹资活动产生的现金流量净额181,088,776.58120,945,781.1135,717,514.77-77,010,871.59
四、汇率变动对现金及现金等价物的影响-385,166.51-308,215.120,225.13-1,954,293.65
五、现金及现金等价物净增加额-181,388,957.54-113,508,505.73244,944,089.88293,337,897.46
  加:期初现金及现金等价物余额620,634,966.11620,634,966.11620,634,966.11327,297,068.65
  期末现金及现金等价物余额439,246,008.57507,126,460.38865,579,055.99620,634,966.11
补充资料:
  净利润--170,012,214.31--386,000,059.67
  资产减值准备--24,283.46-1,013,748.59
  固定资产和投资性房地产折旧-3,446,788.72-6,827,249.92
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-3,446,788.72-6,827,249.92
  无形资产摊销-4,317,518.76-8,574,556.34
  长期待摊费用摊销-1,373,406.86-4,428,812.3
  处置固定资产、无形资产和其他长期资产的损失--205.5--45,298.45
  固定资产报废损失-2,518.59--
  公允价值变动损失--3,257,657.52--9,722,711.24
  财务费用-5,619,902.73-7,392,762.64
  投资损失--13,082,697.49--14,732,400.95
  递延所得税--225,780.58--828,345.34
  其中:递延所得税资产减少--225,780.58--828,345.34
  存货的减少--3,874,028.63--3,445,007.85
  经营性应收项目的减少--24,443,047.44--89,325,542.13
  经营性应付项目的增加--21,088,871.63-11,165,983.67
  其他-13,570,049.44-20,100,329.34
  现金的期末余额-507,126,460.38-620,634,966.11
  减:现金的期初余额-620,634,966.11-327,297,068.65
  现金及现金等价物的净增加额--113,508,505.73-293,337,897.46
公告日期2025-10-302025-08-292025-04-302025-04-19
审计意见(境内)标准无保留意见
TOP↑